Rx-360 is committed to supporting the global pharmaceutical industry in meeting regulatory standards worldwide. In response to the National Medical Products Administration (NMPA) release of Appendices One and Two of Article 310 of the Good […]

The BIOSECURE Act did not arrive with ceremony. It arrived embedded in the National Defense Authorization Act, debated largely in abstractions, and passed with little public attention. But for pharmaceutical and biotechnology companies operating global […]

In a significant move to reshape its pharmaceutical landscape, China has unveiled a comprehensive guideline aimed at deepening the reform of drug and medical device regulation. Issued by the General Office of the State Council […]

Rx-360® is pleased to announce that it has been accepted as a Pilot Center of Excellence (CoE) for the APEC Regulatory Harmonization Steering Committee. The pilot will be focused on the Global Medical Product Supply Chain Integrity Priority Work Area Roadmap.

Rx-360 has released the first episode of The Patient Safety Podcast, a new series that explores patient safety in the pharmaceutical ecosystem.